- Home
- MFA vs ORIC Comparison
MFA vs ORIC Comparison
Compare MFA & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MFA | ORIC |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 976.0M | 973.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MFA | ORIC |
|---|---|---|
| Price | $9.66 | $8.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $10.96 | ★ $19.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | ★ 15.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $279,011,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.85 | N/A |
| P/E Ratio | $11.04 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.85 | $3.90 |
| 52 Week High | $11.08 | $14.93 |
Technical Indicators
Market Signals| Indicator | MFA | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 21.08 |
| Support Level | $9.48 | $10.45 |
| Resistance Level | $9.72 | $12.50 |
| Average True Range (ATR) | 0.14 | 0.73 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 58.33 | 1.17 |
Price Performance
Historical ComparisonAbout MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.